The only requirement for approval is two studies proving the drug awaiting approval is superior to a placebo. Now, the big pharma company can create unlimited trials that do not show this superiority, and possibly inferiority to a placebo, but if two studies develop that meet the requirement, then the drug should be approved, unless deadly safety issues are discovered this early in the game. It raises the question about how efficacious meds really are, overall.